OOIR: Observatory of International Research

Papers

(The H4-Index of Clinical Gastroenterology and Hepatology is 69. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-08-01 to 2025-08-01.)

Article	Citations
Reply	431
Look for a Physical Health Status Surrogate in Hepatocellular Carcinoma: Have we Found the Holy Grail?	326
Simplifying ADR Reporting: A Worthy Goal, but the Devil is in the Details	254
An Unexpected Subepithelial Lesion: Catching the Diagnosis Earlier!	233
Reply	223
Gastric Emphysema With Hepatic Portal Venous Gas Secondary to Acute Gastric Mucosal Lesion	212
Editorial Board	171
Attribution of Colonoscopy Risk Does Not FIT!	170
Table of Contents	164
Exam 1: Treat to Target: The Role of Histologic Healing in Inflammatory Bowel Diseases: A Systematic Review and Meta-analysis	164
Effects of Tenofovir vs Entecavir on Risk of Hepatocellular Carcinoma in Patients With CHB: A Comment for Moving Forward	155
Issue Highlights	152
Elsewhere in the AGA Journals	151
Correction	146
FODMAPs in IBS: Revisiting Restriction	145
Fecal Microbiota Transplantation (FMT) in Ulcerative Colitis: Holding Out for a Superdonor?	141
Blue Notes	141
Familial Risk of Inflammatory Bowel Disease: A Population-Based Cohort Study in South Korea	137
Ambulatory Acute Kidney Injury in Patients With Cirrhosis Is Common and Burdensome	130
Aseptic Abscess Syndrome With Ulcerative Colitis and Pyoderma Gangrenosum	120
Development of an MRI-Based Prediction Model for Anti-TNF Treatment Failure in Perianal Crohn’s Disease: A Multicenter Study	118
Sugar-Sweetened Beverage, Diet Soda, and Nonalcoholic Fatty Liver Disease Over 6 Years: The Framingham Heart Study	117
Front Cover	116
Editorial Board	112
AGA Clinical Practice Update on Management of Inflammatory Bowel Disease in Patients With Malignancy: Commentary	112

Daily or Twice Daily Treatment With Topical Steroids Results in Similar Responses in Eosinophilic Esophagitis	111
PErsistence and Safety of Subcutaneous Infliximab 1 Year After Switch From Intravenous Route in IBD Patients in REMission	110
Fibrosis-4 Index Predicts Long-Term All-Cause, Cardiovascular and Liver-Related Mortality in the Adult Korean Population	108
Hepatic Artery Pseudoaneurysm After Whipple Procedure	105
Predictors of Placebo Induction Response and Remission in Ulcerative Colitis	105
Extended Risankizumab Treatment in Patients With Crohn’s Disease Who Did Not Achieve Clinical Response to Induction Treatment	103
Modified-Release Phosphatidylcholine (LT-02) for Ulcerative Colitis: Two Double-Blind, Randomized, Placebo-Controlled Trials	101
Development of a Simple, Point-of-Care Device to Test Anorectal Function in Patients with Constipation: Randomized Clinical Trial	100
Nonalcoholic Fatty Liver Disease Natural History: Role of Mathematical Modeling	99
Drug-Related Pneumonitis in Patients Receiving Vedolizumab Therapy for Inflammatory Bowel Disease	99
Low Daily Step Count Is Associated With a High Risk of Hospital Admission and Death in Community-Dwelling Patients With Cirrhosis	97
High Hospitalization Rates and Risk Factors Among Frail Patients With Cirrhosis: A 10-year Population-based Cohort Study	94
In the Era of Direct-Acting Antivirals, Liver Transplant Delisting Due to Clinical Improvement for Hepatitis C Remains Infrequent	94
Fecal Immunochemical Tests: The Right Colorectal Cancer Screening Test for the Average-Risk Population?	93
Gut Microbiome Modulation by Antibiotics in Adult Asthma: A Human Proof-of-Concept Intervention Trial	93
An International Multicenter Comparison of IBD-Related Disability and Validation of the IBDDI	91
HBV RNA, Hepatitis B Core-Related Antigen, and Quantitative Hepatitis B Surface Antigen Biomarkers to Predict Outcome of Antiviral Therapy	91
A Case of Pedunculated Esophageal Neuroendocrine Tumor G1	91
Reply	90
Frequent Abnormal Pancreas Imaging in Patients With Pathogenic ATM, BRCA1, BRCA2, and PALB2 Breast Cancer Susceptibility Variants	89
Assessment and Significance of Histologic Activity in Crohn’s Disease	89
Relative Cost-effectiveness of Management Strategies for Uninvestigated Dyspepsia	88
The Evolving Landscape of Colorectal Cancer Screening and Colonoscopy Practice: Insights From the Japan Polyp Study	86
Ileal Pouch Anal Anastomosis for the Management of Ulcerative Colitis Is Associated With Significant Disability	85
Natural History of Patients Lost to Follow-up After Esophageal Food Impaction	85
Overall and Annual Postcolonoscopy Colorectal Cancer Rates in a Large Integrated Healthcare Setting: A Cross-Sectional Study	84
Disaggregating Racial and Ethnic Data: A Step Toward Diversity, Equity, and Inclusion	84
Health Disparities in Inflammatory Bowel Disease Care Driven by Rural Versus Urban Residence: Challenges and Potential Solutions	84
A Novel, Noninvasive Method to Diagnose Active Eosinophilic Esophagitis, Combining Clinical Data and Oral Cavity RNA Levels	83
Association of Statin Usage and the Development of Diabetes Mellitus after Acute Pancreatitis	83
Barrett’s Esophagus Risk Factors in Patients Without Gastroesophageal Reflux: A Large Population-Based Study	83
Australasian Insights and Perspectives on the Burden of Chronic Liver Disease	83
Editorial Board	82
Endoscopic Polypectomy: How Should We Determine Complete Resection Status?	82
Metabolic Signatures of Healthy Lifestyle Patterns and Colorectal Cancer Risk in a European Cohort	79
Endoscopic Sleeve Gastroplasty Plus Lifestyle Intervention in Patients With Metabolic Dysfunction-associated Steatohepatitis: A Multicenter, Sham-controlled, Randomized Trial	78
Long-term Effectiveness and Safety of Risankizumab in Patients with Crohn’s Disease	78
Genetic Diagnosis Guides Treatment of Autoimmune Enteropathy	76
Sex-Related Differences in the Phenotype and Course of Inflammatory Bowel Disease: SEXEII Study of ENEIDA	74
Perianal Disease in Pediatric-Onset Crohn’s Disease: Incidence, Disease Course, and Long-Term Outcomes	74
AGA Clinical Practice Update on New Technology and Innovation for Surveillance and Screening in Barrett’s Esophagus: Expert Review	72
Update in the Treatment of the Complications of Cirrhosis	72
Effects of Rome IV Definitions of Functional Dyspepsia Subgroups in Secondary Care	71
Benefits and Harms of Hepatocellular Carcinoma Surveillance in a Prospective Cohort of Patients With Cirrhosis	70
Low Incidence of Pulmonary Aspiration During Upper Endoscopy in Patients Prescribed a Glucagon-Like Peptide 1 Receptor Agonist	69